Clinical Trial Update: Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study [Phase 2]

View source ↗

Summary

A completed Phase 2 pediatric pilot study assessing the efficacy of intravenous immunoglobulins for Toxic Shock Syndrome. The update reports on efficacy finding…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Toxic Shock Syndrome

Drugs mentioned

• IntraVenous ImmunoGlobulins (intravenous immunoglobulin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Toxic Shock Syndrome | Phase 2 | Status: COMPLETED